Menu

Connect Biopharma Holdings Limited CNTB

Full chart Compare
Set alert

Price alert · CNTB

All alert types
0.73 USD 0.00 (-0.41%)

At closeNov 6, 2026, 7:51 PM EST

0.74 +0.01 +1.55%

After hours · Nov 6, 7:51 PM ET

0.71 Day range 0.7615
0.7287 52-week range 3.69
YTD
-74.16%
1 year
-56.10%

Revenue & Expenses

Other Income → Expenses: $2.79MExpenses → Selling, General & Admin: $20.34MExpenses → Research & Development: $37.80MExpenses → Income Tax: $197.00KGross Profit → Expenses: $64.00KRevenue → Gross Profit: $64.00KNet Loss → Expenses: $55.48MOther Income$2.79MGross Profit$64.00KNet Loss$55.48MExpenses$58.34MSelling, General & Admin$20.34MResearch & Development$37.80MIncome Tax$197.00KRevenue$64.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

CNTB annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
64.00K26.03M000
64.00K26.03M000
-58.07M-22.45M-69.06M-119.32M-98.11M
-55.48M-15.63M-62.11M-118.09M-202.27M
-1.00-0.28-1.13-2.15-3.88
CNTB annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
38.34M78.23M105.66M79.01M267.72M
56.08M101.28M127.38M174.01M291.05M
14.10M9.12M25.88M16.52M18.80M
690.00K178.00K465.00K431.00K125.00K
41.98M92.17M101.50M157.49M272.26M
CNTB annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-51.21M-23.61M-47.74M-101.52M-84.32M
9.82M-3.45M74.98M-86.24M-5.21M
1.09M227.00K45.00K-85.00K202.22M
-432.00K-750.00K2.86M-4.41M-7.28M
-39.89M-27.43M26.72M-187.85M112.69M